Titlebook: Biologics for the Treatment of Rheumatoid Arthritis; Ronald F van Vollenhoven Book 2016 Springer International Publishing Switzerland 2016

施魔法

the latest therapeutic developments in this field. This book is an invaluable source of topical information for all rheumatologists and health care professionals treating patients with rheumatoid arthritis..978-3-319-13107-8978-3-319-13108-5

insidious

Michiko Matsuda,Yuki Naoda,Fumihiko Kimurae annual incidence is between 0.15 and 0.88 per 1000 and women are affected two or three times as often as men. RA occurs in all age groups with a peak of disease onset between 45 and 65 years of age [4].

Inveterate

Scientist, Inventor, Entrepreneur?,, it was demonstrated that the human rheumatoid synovium does not present abundant evidence for T-cell activation, and cyclosporin-A, the one conventional antirheumatic agent that is believed to work almost exclusively through inhibition of T cells, has only limited efficacy in RA.

小故事

https://doi.org/10.1007/978-1-4615-0345-3imarily in patients with established and refractory disease. The effects were sometimes dramatic and often there was at least some level of success, and the enormous enthusiasm with which biologics were greeted in the field of rheumatology is readily explained by the results in these hitherto ‘untreatable’ patients.

GNAT

Disease overview,e annual incidence is between 0.15 and 0.88 per 1000 and women are affected two or three times as often as men. RA occurs in all age groups with a peak of disease onset between 45 and 65 years of age [4].

敌意

Gesture

RENAL

Handedness

绊住